Continuing its ambitious growth journey, SHL Medical has acquired Superior Tooling Inc., a US-based manufacturing company specializing in plastic injection molds.
Menu
FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses enters a non-exclusive strategic partnership agreement with SHL Medical (SHL), a world-leading solutions provider of advanced drug delivery systems.
Visit Booth #D60 during Pharmapack Europe 2024 on January 24-25 and learn about SHL Medical’s Molly® Connected Cap, Innovation Partnership, and more!
SHL’s continuous improvement efforts have been recognized with a total of three awards from Taiwan’s two prestigious competitions – Excellent Practice Award (EPA) from the Association of Quality Manager and Taiwan Continuous Improvement Awards (TCIA) from Corporate Synergy Development Center.
In the Sustainability Issue of ONdrug Delivery magazine, SHL Medical’s ESG Project Manager discusses the development of single-use autoinjectors in the context of SHL’s sustainable design principles and decarbonization goals.
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target, underlining the company’s dedication to remaining transparent and accountable throughout its entire sustainability journey.
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target, underlining the company’s dedication to remaining transparent and accountable throughout its entire sustainability journey.
SHL Medical has joined the NSTC Science Train Program for the second consecutive year as part of its human-centered sustainability approach.
SHL and Lifecore will exchange knowledge and experience in their respective fields, enabling both companies to provide their customers unparalleled guidance in CDMO services and best-in-class options for drug delivery device development.
